Diabetes

AI in diabetes care – Paving the way for a new era of healthcare

Afon Technology is a leader in advanced medical technology focused on transforming diabetes care. Brad Love and Dan Fowles discuss how the company uses big data to create personalised health solutions that can significantly impact the lives of millions.

Is the UK heading for a “perfect storm” of diabetes referrals?

Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.

People with obesity nearly three times as likely to get Type 2 diabetes

New research by the American Heart Association finds that obesity is a factor in almost half of all new cases, with obese individuals significantly more likely to get Type 2 diabetes.

Diabetics are concerned about disrupted insulin supplies due to Brexit

Diabetics living in the UK are worried about disruption to insulin supplies as a result of Brexit, according to a new social media study.

Changing mealtimes could prevent type 2 diabetes

In a new study, researchers will examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.

Exercise during the first trimester may reduce gestational diabetes risk

According to a new study, pregnant women who exercise more during the first trimester may have a lower risk of developing gestational diabetes.

The rise of real-world data and digital tools: Conducting remote clinical trials in a pandemic

Here, Mark Clements, MD PhD, paediatric endocrinologist, clinical investigator, and chief medical officer at Glooko Inc. takes part in a Q&A regarding his perspectives on remote clinical trials and data management tools.

Consequences of foetal development in a “sweet” uterus: The short-and long-term transgenerational outcomes

Jane C Khoury & Shelley R Ehrlich from Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, highlight the consequences of foetal development in a “sweet” uterus – including the short- and long-term transgenerational outcomes.

The beginning of the end for Type 1 diabetes: A new view from immunotherapy science

Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.

How COVID-19 has renewed momentum to improve inpatient diabetes care

Olivia Burr, Inpatient Care Lead at Diabetes UK, explains how COVID-19 has renewed momentum to improve inpatient diabetes care.

Diabetes: How can we improve patient wellbeing & national health outcomes?

Claus Møldrup, DrugsDisclosed.com Founder and Former Professor in Social Pharmacy at the University of Copenhagen, turns the spotlight on diabetes and explores how to improve patient wellbeing and national health outcomes.

Diabetes patients are three times as likely to have severe COVID

While diabetes has been declared as a signifier for infection complications, researchers now say that data suggests it is three times as likely these individuals have severe COVID or are hospitalised.

Nutritional and health benefits of dietary products made from fish side streams

Katerina Kousoulaki, Christos Tsatsanis, Tone-Kari K. Østbye and Francisco J. Barba of the AQUABIOPRO-FIT project discuss the health benefits of dietary products made from fish side streams.

Diabetes increases risk of COVID-19 brain complications

New research finds that bleeding and stroke are COVID-19 brain complications that are more frequent in people with diabetes and hypertension.

The future of treating gestational diabetes

Dr Lucy Mackillop, Chief Medical Officer, Sensyne Health discusses the future of treating gestational diabetes.

How to fight diabetes with improved body composition

Here the InBody Clinical Team explain how improved body composition can help fight type 2 diabetes.

Impact of COVID-19 on healthcare for patients with diabetes

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders